Cargando…

Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore

OBJECTIVE: We conducted a cross-sectional study to adapt and validate the Hypoglycemia Fear Survey-II (HFS-II) for use in Singapore among persons with type 1 and 2 diabetes mellitus. RESEARCH DESIGN AND METHODS: A total of 144 patients with type 1 or 2 diabetes on insulin therapy for at least a year...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Amanda Yun Rui, Xin, Xiaohui, Tan, Wee Boon, Gardner, Daphne Su-Lyn, Goh, Su-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530240/
https://www.ncbi.nlm.nih.gov/pubmed/28761646
http://dx.doi.org/10.1136/bmjdrc-2016-000329
_version_ 1783253239591862272
author Lam, Amanda Yun Rui
Xin, Xiaohui
Tan, Wee Boon
Gardner, Daphne Su-Lyn
Goh, Su-Yen
author_facet Lam, Amanda Yun Rui
Xin, Xiaohui
Tan, Wee Boon
Gardner, Daphne Su-Lyn
Goh, Su-Yen
author_sort Lam, Amanda Yun Rui
collection PubMed
description OBJECTIVE: We conducted a cross-sectional study to adapt and validate the Hypoglycemia Fear Survey-II (HFS-II) for use in Singapore among persons with type 1 and 2 diabetes mellitus. RESEARCH DESIGN AND METHODS: A total of 144 patients with type 1 or 2 diabetes on insulin therapy for at least a year completed the HFS-II between September and December 2013 in the Diabetes Center at Singapore General Hospital. We examined the validity (content, concurrent and discriminant validity, and construct validity) and reliability (internal consistency and test–retest reliability) of the instrument. Content validity was established using cognitive interviews. Construct validity was assessed using confirmatory factor analysis (CFA) followed by exploratory factor analysis (EFA) after the hypothesized two-factor structure was not confirmed by CFA. Measures of anxiety (Generalized Anxiety Disorder-7 (GAD-7)) and depression (Patient Health Questionnaire-9 (PHQ-9)) were used to establish concurrent validity; history of severe hypoglycemia and status of glycemic control were used to establish discriminant validity. Internal consistency was measured by Cronbach’s α; test–retest reliability was measured by intracluster correlation coefficient (ICC). RESULTS: Scores of the adapted HFS-II had moderate positive correlations with measures of anxiety and depression scores (r(anxiety)=0.41, p<0.01; r(depression)=0.37, p<0.01()). Patients with a recent history of severe hypoglycemia had higher HFS-II scores than those without (mean difference=9, p<0.01). Patients with poor glycemic control had higher HFS-II scores than those with good control (p<0.05). The original two-factor structure was not confirmed in our sample. EFA results suggested a three-factor solution with the original Behavior subscale splitting into two dimensions. The adapted HFS-II displayed good internal consistency (Cronbach’s α=0.93) and test–retest reliability (ICC=0.75). CONCLUSIONS: The adapted HFS-II has good content, concurrent and discriminant validity, and reliability, but its constructvalidity was not proven with the Behavior subscale turning out to be non-unidimensional.
format Online
Article
Text
id pubmed-5530240
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55302402017-07-31 Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore Lam, Amanda Yun Rui Xin, Xiaohui Tan, Wee Boon Gardner, Daphne Su-Lyn Goh, Su-Yen BMJ Open Diabetes Res Care Clinical Care/Education/Nutrition/Psychosocial Research OBJECTIVE: We conducted a cross-sectional study to adapt and validate the Hypoglycemia Fear Survey-II (HFS-II) for use in Singapore among persons with type 1 and 2 diabetes mellitus. RESEARCH DESIGN AND METHODS: A total of 144 patients with type 1 or 2 diabetes on insulin therapy for at least a year completed the HFS-II between September and December 2013 in the Diabetes Center at Singapore General Hospital. We examined the validity (content, concurrent and discriminant validity, and construct validity) and reliability (internal consistency and test–retest reliability) of the instrument. Content validity was established using cognitive interviews. Construct validity was assessed using confirmatory factor analysis (CFA) followed by exploratory factor analysis (EFA) after the hypothesized two-factor structure was not confirmed by CFA. Measures of anxiety (Generalized Anxiety Disorder-7 (GAD-7)) and depression (Patient Health Questionnaire-9 (PHQ-9)) were used to establish concurrent validity; history of severe hypoglycemia and status of glycemic control were used to establish discriminant validity. Internal consistency was measured by Cronbach’s α; test–retest reliability was measured by intracluster correlation coefficient (ICC). RESULTS: Scores of the adapted HFS-II had moderate positive correlations with measures of anxiety and depression scores (r(anxiety)=0.41, p<0.01; r(depression)=0.37, p<0.01()). Patients with a recent history of severe hypoglycemia had higher HFS-II scores than those without (mean difference=9, p<0.01). Patients with poor glycemic control had higher HFS-II scores than those with good control (p<0.05). The original two-factor structure was not confirmed in our sample. EFA results suggested a three-factor solution with the original Behavior subscale splitting into two dimensions. The adapted HFS-II displayed good internal consistency (Cronbach’s α=0.93) and test–retest reliability (ICC=0.75). CONCLUSIONS: The adapted HFS-II has good content, concurrent and discriminant validity, and reliability, but its constructvalidity was not proven with the Behavior subscale turning out to be non-unidimensional. BMJ Publishing Group 2017-06-08 /pmc/articles/PMC5530240/ /pubmed/28761646 http://dx.doi.org/10.1136/bmjdrc-2016-000329 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Clinical Care/Education/Nutrition/Psychosocial Research
Lam, Amanda Yun Rui
Xin, Xiaohui
Tan, Wee Boon
Gardner, Daphne Su-Lyn
Goh, Su-Yen
Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
title Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
title_full Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
title_fullStr Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
title_full_unstemmed Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
title_short Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
title_sort psychometric validation of the hypoglycemia fear survey-ii (hfs-ii) in singapore
topic Clinical Care/Education/Nutrition/Psychosocial Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530240/
https://www.ncbi.nlm.nih.gov/pubmed/28761646
http://dx.doi.org/10.1136/bmjdrc-2016-000329
work_keys_str_mv AT lamamandayunrui psychometricvalidationofthehypoglycemiafearsurveyiihfsiiinsingapore
AT xinxiaohui psychometricvalidationofthehypoglycemiafearsurveyiihfsiiinsingapore
AT tanweeboon psychometricvalidationofthehypoglycemiafearsurveyiihfsiiinsingapore
AT gardnerdaphnesulyn psychometricvalidationofthehypoglycemiafearsurveyiihfsiiinsingapore
AT gohsuyen psychometricvalidationofthehypoglycemiafearsurveyiihfsiiinsingapore